This report on the U.S. market for over-the-counter (OTC) cough, cold, sinus and allergy (CCSA) medication presents an in-depth analysis of the performance of various CCSA drugs in the U.S. market. The analysis captures the performance of the market players, drug categories, and leading brands in terms of revenues and growth. It also identifies key issues, drivers, challenges, regulations, and trends affecting the marketplace.
In addition, the report provides a detailed analysis of consumer demographics and preferences in terms of dosage forms, brand names, and distribution/retail channels. Media spending by brand and various innovative promotional activities and marketing approaches are reviewed in detail, and extensive market share information is provided at both the marketer and branded product levels. New product launches in traditional and alternative therapy spheres are reviewed, and the impact of product messaging, packaging, and various other retail trends are discussed.
For the purposes of this study, the market for OTC CCSA products are segmented in the following main categories and subcategories.
- Cold/Allergy/Sinus Medication
- Antihistamines
- Non-sedating antihistamine
- Decongestants
- Cough Medication
- Antitussives
- Expectorants
- Combination Products
- Cold/allergy/sinus medication
- Cough medication
- Other
- Cold/allergy/sinus medication
- Cough medication
- Nasal products
- Nasal aspirators
- Nasal spray/drops/inhaler
- Nasal strips
- Mast cell stabilizers
- Chest rubs
In addition, 11 top competitors are profiled in depth including product lines, product performance, product mix, and strategic approach.
View Cart
